SNES: The proof of the pudding: SenesTech will provide Washington DC with 4,500 tanks of ContraPest following completion of a four month study.

Loading...
Loading...

By Ian Gilson, PhD, CFA

NASDAQ:SNES

READ THE FULL SNES RESEARCH REPORT

Following the completion of a four month study of the effectiveness of ContraPest, there is no longer any doubt that ContraPest is an effective treatment for rat control.

The District of Columbia will dramatically increase the use of the contraceptive to counteract the reopening of eateries and the use of public spaces to consume food. The four month study using videography showed a decline from 51% to 88% in rat population where ContraPest was deployed.

The closure of restaurants had caused rats to migrate away from eating sites to find food and now that restaurants are beginning to reopen we would expect the rats to move back to the traditional sites. It is critical that the migration is interrupted before an infestation occurs.

SenesTech SNES will supply DC with about 4,500 tanks of active ingredient to Pestmaster Services, a local pest management company, for storage and deployment at no cost to Washington, DC, (DC will pay for the deployment).

SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR. 

DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks provides and Zacks receives quarterly payments totaling a maximum fee of $40,000 annually for these services. Full Disclaimer HERE.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Penny Stocks
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...